Headlines about Nanosphere (NASDAQ:NSPH) have trended somewhat positive on Thursday, according to Accern Sentiment. The research firm identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Nanosphere earned a daily sentiment score of 0.11 on Accern’s scale. Accern also assigned headlines about the medical research company an impact score of 46.01 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

TRADEMARK VIOLATION WARNING: This news story was originally posted by Watch List News and is owned by of Watch List News. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international trademark and copyright law. The legal version of this news story can be accessed at https://www.watchlistnews.com/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-nanosphere-nsph-stock-price/1673731.html.

Nanosphere Company Profile

Nanosphere, Inc is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. The Verigene System includes a molecular diagnostics workstation that is a single use consumable for testing.

Insider Buying and Selling by Quarter for Nanosphere (NASDAQ:NSPH)

Receive News & Ratings for Nanosphere Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanosphere Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.